Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Completed · Not applicable
Conditions studied: Hereditary Breast and Ovarian Cancer
In brief
Participating in genetic cancer risk assessments (GCRA) for hereditary breast and ovarian cancer can inform treatment and risk management decisions and improve breast cancer outcomes. However, Latina and Black women underuse GCRA services, which may increase breast cancer disparities. This study will adapt and test the impact of an easily scalable novel Tutoring System intervention to enhance GCRA use and improve psychosocial outcomes in a clinical sample of underserved Latina and Black women at risk of hereditary breast and ovarian cancer.
Key facts
- Study ID
- NCT03511690
- Run by
- Georgetown University
- People needed
- 95
- Starts
- 2017-07-01
- Expected to finish
- 2022-02-20
- Last updated by the study team
- 2022-04-25
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Self-identify as Black and/or Latina
- English proficiency
- Be 18 years old or older
- Be able to provide informed consent
- Be at risk of carrying HBOC mutation using personal/family cancer histories based on the NCCN guidelines
You may not qualify if…
- Prior participation in genetic counseling or genetic testing for hereditary cancer risk.
Where it is running
- Capital Breast Care Center — Washington D.C., District of Columbia, United States
- Georgetown University — Washington D.C., District of Columbia, United States
- Nueva Vida — Alexandria, Virginia, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.